Literature DB >> 22244474

Prevalence of hyperprolactinemia in adolescents and young women with menstruation-related problems.

Dong-Yun Lee1, Yoon-Kyung Oh, Byung-Koo Yoon, DooSeok Choi.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the prevalence of hyperprolactinemia in adolescents and young women with menstrual problems. STUDY
DESIGN: This study included 1704 young women with menstruation-related problems. The patients were classified into group I (age, 11-20 years) or group II (age, 21-30 years); the prevalence of hyperprolactinemia was analyzed according to age and categories of menstruation-related problems.
RESULTS: For primary amenorrhea and oligomenorrhea, the prevalence of hyperprolactinemia was low in both groups. However, hyperprolactinemia was a relatively common cause of secondary amenorrhea (5.5% for group I and 13.8% for group II, respectively); it was more frequent in group II (P = .001); the prevalence of prolactinoma was also higher in group II (P = .015). For abnormal uterine bleeding, hyperprolactinemia was more common in group II (2.6% for group I and 9.4% for group II; P < .001), but causes were similar.
CONCLUSION: Hyperprolactinemia is not rare in young women with menstruation-related problems; its prevalence varies according to age and manifestations.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22244474     DOI: 10.1016/j.ajog.2011.12.010

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

Review 1.  The Unexplored Crossroads of the Female Athlete Triad and Iron Deficiency: A Narrative Review.

Authors:  Dylan L Petkus; Laura E Murray-Kolb; Mary Jane De Souza
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

2.  Efficacy of Combined Cabergoline and Metformin Compared to Metformin Alone on Cycle Regularity in Patients with Polycystic Ovarian Disease with Hyperprolactinemia: A Randomized Clinical Trial.

Authors:  Mervat Ali Mohamed Elsersy
Journal:  J Obstet Gynaecol India       Date:  2017-06-24

3.  Endocrine Abnormalities in Adolescents with Menstrual Disorders.

Authors:  Siddhesh R Rajiwade; Haritha Sagili; R Soundravally; L Subitha
Journal:  J Obstet Gynaecol India       Date:  2017-07-17

4.  Effect of Chinese medical herbs-Huiru Yizeng Yihao on hyperprolactinemia and hyperplasia of mammary gland in mice.

Authors:  Xiong Wang; Yong-Gang Chen; Li Ma; Zhi-Hui Li; Ju-Yi Li; Xin-Guo Liu; Ji-Li Zou; Jin-Hu Wu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-05-16

Review 5.  Endocrine autoimmune diseases and female infertility.

Authors:  Aritro Sen; Vitaly A Kushnir; David H Barad; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2013-11-05       Impact factor: 43.330

6.  Water Extract of Fructus Hordei Germinatus Shows Antihyperprolactinemia Activity via Dopamine D2 Receptor.

Authors:  Xiong Wang; Li Ma; En-Jing Zhang; Ji-Li Zou; Hao Guo; Si-Wei Peng; Jin-Hu Wu
Journal:  Evid Based Complement Alternat Med       Date:  2014-08-28       Impact factor: 2.629

7.  Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea.

Authors:  Robert P Millar; Charlotte Sonigo; Richard A Anderson; Jyothis George; Luigi Maione; Sylvie Brailly-Tabard; Philippe Chanson; Nadine Binart; Jacques Young
Journal:  J Endocr Soc       Date:  2017-10-16

8.  Pituitary magnetic resonance imaging abnormalities in young female patients with hypogonadotropic hypogonadism.

Authors:  Ji-Yeon Kang; Sang Heum Kim; Hounyoung Kim; Hyojin Ki; Mee-Hwa Lee
Journal:  Obstet Gynecol Sci       Date:  2019-06-21

9.  Reproductive function and pregnancy outcomes in women treated for idiopathic hyperprolactinemia: A non-randomized controlled study.

Authors:  Khatuna Sokhadze; Sophio Kvaliashvili; Jenaro Kristesashvili
Journal:  Int J Reprod Biomed       Date:  2020-12-21

Review 10.  The Menstrual Disturbances in Endocrine Disorders: A Narrative Review.

Authors:  Marzieh Saei Ghare Naz; Marzieh Rostami Dovom; Fahimeh Ramezani Tehrani
Journal:  Int J Endocrinol Metab       Date:  2020-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.